ERBB2 and breast neoplasm: The overexpression of epidermal growth factor 2 (HER2) in women, together with the lack of steroid hormone receptors, is associated with more aggressive breast tumor growth and the acquisition of DR through major pathways such as the wingless-type MMTV integration site (Wnt) family or the Rous sarcoma proto-oncogene (cSRC).